Nancy J. Hutson

Companies

• BioCryst PharmaceuticalsBoard member Jan 23, 2012 to now¹
• Clearside Biomedical, Inc.Board member Apr 23, 2020 to Jun 21, 2024²
• PhaseBio Pharmaceuticals IncBoard member Oct 17, 2018 to May 19, 2023³
• Endo International plcBoard member Mar 4, 2014 to Jun 15, 2021⁴
• Cubist PharmaceuticalsBoard member Jun 16, 2008 to Jan 21, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BioCryst Pharmaceuticals BCRX99,138 shares⁶$791.6K at $7.99Jun 12, 2025
• PPPhaseBio Pharmaceuticals Inc41,510 shares⁷May 19, 2023
• CBClearside Biomedical, Inc.93,000 shares⁸Oct 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 12, 2025Granted 12,500 shares of BioCryst Pharmaceuticals⁶
• Dec 13, 2024Sold 7,000 shares at $7.54 of BioCryst Pharmaceuticals⁹
• Jun 12, 2024Granted 6,820 shares of BioCryst Pharmaceuticals¹⁰
• May 20, 2024Bought 5,000 shares at $6.38 of BioCryst Pharmaceuticals¹¹
• Oct 3, 2023Bought 10,000 shares at $0.86 of Clearside Biomedical, Inc.⁸
• Jun 14, 2023Sold 12,866 shares at $8.04 of BioCryst Pharmaceuticals¹²
• Jun 13, 2023Granted 16,745 shares of BioCryst Pharmaceuticals¹²
• May 19, 2023Exercised options 3,750 shares of PhaseBio Pharmaceuticals Inc⁷
• Nov 17, 2022Bought 30,000 shares at $1.33 of Clearside Biomedical, Inc.¹³
• Jun 7, 2022Granted 12,866 shares of BioCryst Pharmaceuticals¹⁴
• Nov 8, 2021Exercised options 7,400 shares at $3.15 of PhaseBio Pharmaceuticals Inc¹⁵
• Nov 5, 2021Exercised options 1,500 shares at $3.15 of PhaseBio Pharmaceuticals Inc¹⁵
• Nov 5, 2021Exercised options 24,860 shares at $2.26 of PhaseBio Pharmaceuticals Inc¹⁵
• Oct 29, 2021Exercised options 15,000 shares at $2.09 of Clearside Biomedical, Inc.¹⁶
• Oct 29, 2021Exercised options 25,000 shares at $2.00 of Clearside Biomedical, Inc.¹⁶
• Oct 15, 2021Sold 105,000 shares at $15.40 of BioCryst Pharmaceuticals¹⁷
• Oct 15, 2021Exercised options 30,000 shares at $3.22 of BioCryst Pharmaceuticals¹⁷
• Oct 15, 2021Exercised options 15,000 shares at $1.71 of BioCryst Pharmaceuticals¹⁷
• Oct 15, 2021Exercised options 30,000 shares at $5.13 of BioCryst Pharmaceuticals¹⁷
• Oct 15, 2021Exercised options 30,000 shares at $2.91 of BioCryst Pharmaceuticals¹⁷
• Aug 18, 2021Bought 3,000 shares at $3.08 of PhaseBio Pharmaceuticals Inc¹⁸